Literature DB >> 17383861

Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart.

Zhong Ming Qian1, Yan Zhong Chang, Gina Leung, Jun Rong Du, Li Zhu, Qin Wang, Lijian Niu, You Jia Xu, Lei Yang, Kwok Ping Ho, Ya Ke.   

Abstract

Iron-mediated injury plays an important role in a number of heart disorders. Studies on heart iron are therefore crucial for understanding the causes of excessive heart iron. Heart cells have the ability to accumulate transferrin-bound-iron via the transferrin receptor and non-transferrin-bound-iron probably via the L-type Ca2+ channel and the divalent metal transporter1. However, little is known about the mechanisms of iron export in the heart cells. Here, we investigated expression of iron exporters including ferroportin 1 (Fpn1), ceruloplasmin (CP) and hephaestin (Heph) and provided evidence for their existence in the heart. We demonstrated that iron has a significant effect on expression of Fpn1 and CP, but not Heph. Treatment of a high-iron diet induced a significant increase in Fpn1, a decrease in CP but no change in Heph mRNA and protein. The control of Fpn1 and CP protein expression by iron was parallel to that of their mRNA expression, suggesting a transcriptional regulation of Fpn1 and CP by iron. The existence of these proteins in the heart implies that they might have a role in heart iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383861     DOI: 10.1016/j.bbadis.2007.02.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

Authors:  James A Duce; Andrew Tsatsanis; Michael A Cater; Simon A James; Elysia Robb; Krutika Wikhe; Su Ling Leong; Keyla Perez; Timothy Johanssen; Mark A Greenough; Hyun-Hee Cho; Denise Galatis; Robert D Moir; Colin L Masters; Catriona McLean; Rudolph E Tanzi; Roberto Cappai; Kevin J Barnham; Giuseppe D Ciccotosto; Jack T Rogers; Ashley I Bush
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

Review 2.  Ion channelopathies and migraine pathogenesis.

Authors:  Cassie L Albury; Shani Stuart; Larisa M Haupt; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2017-04-07       Impact factor: 3.291

3.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

4.  Functional role of the putative iron ligands in the ferroxidase activity of recombinant human hephaestin.

Authors:  Ganna Vashchenko; Ross T A Macgillivray
Journal:  J Biol Inorg Chem       Date:  2012-09-09       Impact factor: 3.358

Review 5.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

6.  Hepcidin regulation of iron transport.

Authors:  James F Collins; Marianne Wessling-Resnick; Mitchell D Knutson
Journal:  J Nutr       Date:  2008-11       Impact factor: 4.798

Review 7.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

8.  Biodistribution, Clearance And Morphological Alterations Of Intravenously Administered Iron Oxide Nanoparticles In Male Wistar Rats.

Authors:  Usha Singh Gaharwar; Ramovatar Meena; Paulraj Rajamani
Journal:  Int J Nanomedicine       Date:  2019-12-06

Review 9.  Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.

Authors:  Ewa A Jankowska; Stephan von Haehling; Stefan D Anker; Iain C Macdougall; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2012-10-25       Impact factor: 29.983

10.  Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.

Authors:  Ekatherina Stoyanova; Guy Cloutier; Hady Felfly; Wafaa Lemsaddek; Nicolas Ah-Son; Marie Trudel
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.